PRISTIQ® (desvenlafaxine)

PRISTIQ® (desvenlafaxine) Extended-Release Tablets

PRISTIQ® (desvenlafaxine) PRISTIQ is an extended-release tablet for oral administration that contains desvenlafaxine succinate, a structurally novel SNRI for the treatment of MDD. Desvenlafaxine (O-desmethylvenlafaxine) is the major active metabolite of the antidepressant venlafaxine, a medication used to treat major depressive disorder. Desvenlafaxine is designated RS-4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol and has the empirical formula of C16H25NO2 (free base) …

PRISTIQ® (desvenlafaxine) Extended-Release Tablets Read More »